Role of Tat protein in HIV neuropathogenesis (Q37519397)

20 August 2017

1 reference

title

Role of Tat protein in HIV neuropathogenesis (English)

1 reference

20 August 2017

0 references

1 reference

Wenxue Li

1

1 reference

20 August 2017

Guanhan Li

series ordinal

2

1 reference

20 August 2017

Joseph Steiner

series ordinal

3

1 reference

20 August 2017

Avindra Nath

series ordinal

4

1 reference

20 August 2017

21 March 2009

1 reference

20 August 2017

Neurotoxicity Research

1 reference

20 August 2017

16

1 reference

20 August 2017

3

1 reference

20 August 2017

205-220

1 reference

https://scigraph.springernature.com/pub.10.1007/s12640-009-9047-8

20 August 2017

0 references

cites work

Discovery and characterization of an HIV-1 Tat antagonist

1 reference

https://api.crossref.org/works/10.1007%2FS12640-009-9047-8

Glutamate receptor channels in isolated patches from CA1 and CA3 pyramidal cells of rat hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-009-9047-8

Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-009-9047-8

HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-009-9047-8

Evidence that Par-4 participates in the pathogenesis of HIV encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-009-9047-8

Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-009-9047-8

HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-009-9047-8

HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-009-9047-8

Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-009-9047-8

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

21 January 2018

1 reference

12 December 2020

HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism

1 reference

12 December 2020

Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain

1 reference

12 December 2020

Human immunodeficiency virus-1 protein tat and methamphetamine interactions

1 reference

12 December 2020

PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells

1 reference

12 December 2020

Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins

1 reference

12 December 2020

HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier

1 reference

12 December 2020

HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes

1 reference

12 December 2020

Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement

1 reference

12 December 2020

Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues

1 reference

12 December 2020

Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia

1 reference

12 December 2020

TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation

1 reference

12 December 2020

Expression of HIV regulatory and structural mRNA in the central nervous system.

1 reference

12 December 2020

Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes.

1 reference

12 December 2020

Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation

1 reference

12 December 2020

Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus

1 reference

12 December 2020

Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures.

1 reference

12 December 2020

Rational optimization of a HIV-1 Tat inhibitor: rapid progress on combinatorial lead structures

1 reference

12 December 2020

Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.

1 reference

12 December 2020

Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain.

1 reference

12 December 2020

Cationic TAT peptide transduction domain enters cells by macropinocytosis.

1 reference

12 December 2020

Brain-derived HIV-1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity.

1 reference

12 December 2020

MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis

1 reference

12 December 2020

HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.

1 reference

12 December 2020

Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors.

1 reference

12 December 2020

Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor

1 reference

12 December 2020

HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS

1 reference

12 December 2020

Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation

1 reference

12 December 2020

HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity

1 reference

12 December 2020

A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition

1 reference

12 December 2020

Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif

1 reference

12 December 2020

Design and synthesis of a novel peptidomimetic inhibitor of HIV-1 Tat-TAR interactions: squaryldiamide as a new potential bioisostere of unsubstituted guanidine

1 reference

12 December 2020

Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes

1 reference

12 December 2020

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia

1 reference

12 December 2020

Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells

1 reference

12 December 2020

HIV-1 Tat inhibits long-term potentiation and attenuates spatial learning [corrected].

1 reference

12 December 2020

The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence

1 reference

12 December 2020

Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures

1 reference

12 December 2020

Mutation of Leu25and Val27Introduces CC Chemokine Activity into Interleukin-8

1 reference

12 December 2020

Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration

1 reference

12 December 2020

Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells.

1 reference

12 December 2020

Simvastatin protects against amyloid beta and HIV-1 Tat-induced promoter activities of inflammatory genes in brain endothelial cells

1 reference

12 December 2020

Intracellular trafficking and interactions of the HIV-1 Tat protein

1 reference

12 December 2020

Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity

1 reference

12 December 2020

Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine

1 reference

12 December 2020

U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes

1 reference

12 December 2020

Assessment of neuronal density in the putamen in human immunodeficiency virus (HIV) infection. Application of stereology and spatial analysis of quadrats.

1 reference

12 December 2020

HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation

1 reference

12 December 2020

Limited role of COX-2 in HIV Tat-induced alterations of tight junction protein expression and disruption of the blood-brain barrier

1 reference

12 December 2020

Exogenous tat protein activates central nervous system-derived endothelial cells

1 reference

12 December 2020

Tat is required for efficient HIV-1 reverse transcription

1 reference

12 December 2020

Durhamycin A, a potent inhibitor of HIV Tat transactivation

1 reference

12 December 2020

Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.

1 reference

12 December 2020

Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells

1 reference

12 December 2020

Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator

1 reference

12 December 2020

Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein

1 reference

12 December 2020

Acute in vivo neurotoxicity of peptides from Maedi Visna virus transactivating protein Tat.

1 reference

12 December 2020

Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription

1 reference

12 December 2020

Tat protein from human immunodeficiency virus forms a metal-linked dimer

1 reference

12 December 2020

Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands

1 reference

12 December 2020

Long-term effects of HTLV-1 on brain astrocytes: sustained expression of Tax-1 associated with synthesis of inflammatory mediators.

1 reference

12 December 2020

Protein transduction: a new tool for the study of cellular ageing and senescence

1 reference

12 December 2020

Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport

1 reference

12 December 2020

HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress.

1 reference

12 December 2020

Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans

1 reference

12 December 2020

A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator

1 reference

12 December 2020

A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor.

1 reference

12 December 2020

Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons

1 reference

12 December 2020

Blocking HIV replication by targeting Tat protein

1 reference

12 December 2020

Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine

1 reference

12 December 2020

Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat

1 reference

12 December 2020

Human T-cell leukemia virus type 1 Tax protein induces the expression of lymphocyte chemoattractant SDF-1/PBSF.

1 reference

12 December 2020

Human immunodeficiency virus (HIV) Tat-reactive antibodies present in normal HIV-negative sera and depleted in HIV-positive sera. Identification of the epitope

1 reference

12 December 2020

Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication

1 reference

12 December 2020

Excitatory effects of human immunodeficiency virus 1 Tat on cultured rat cerebral cortical neurons

1 reference

12 December 2020

Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia.

1 reference

12 December 2020

[Neurotoxicity in mice due to cysteine-rich parts of visna virus and HIV-1 Tat proteins]

1 reference

12 December 2020

Protein/peptide transduction domains: potential to deliver large DNA molecules into cells.

1 reference

12 December 2020

High frequency of defective vpu compared with tat and rev genes in brain from patients with HIV type 1-associated dementia.

1 reference

12 December 2020

In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 Tat-induced alterations in dopamine transmission

1 reference

12 December 2020

Expression of stromal cell-derived factor 1alpha protein in HIV encephalitis

1 reference

12 December 2020

Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function

1 reference

12 December 2020

Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis

1 reference

12 December 2020

Silencing the PTEN gene is protective against neuronal death induced by human immunodeficiency virus type 1 Tat.

1 reference

12 December 2020

Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-kappaB (NF-kappaB)-dependent mechanism

1 reference

12 December 2020

Intranasal tat alters gene expression in the mouse brain

1 reference

12 December 2020

A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus

1 reference

12 December 2020

Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist

1 reference

12 December 2020

In vivo protein transduction: delivery of a biologically active protein into the mouse

1 reference

12 December 2020

Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells

1 reference

12 December 2020

HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors

1 reference

12 December 2020

Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.

1 reference

12 December 2020

Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1.

1 reference

12 December 2020

Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C- and cAMP-dependent protein kinase pathways

1 reference

12 December 2020

HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence.

1 reference

12 December 2020

Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages

1 reference

12 December 2020

Studies on the synthesis of durhamycin A: stereoselective synthesis of a model aglycone

1 reference

12 December 2020

HIV-1 tat molecular diversity and induction of TNF-alpha: implications for HIV-induced neurological disease

1 reference

12 December 2020

Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents

1 reference

12 December 2020

HTLV-I induced myeloneuropathy in WKAH rats: apoptosis and local activation of the HTLV-I pX and TNF-alpha genes implicated in the pathogenesis.

1 reference

12 December 2020

AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity

1 reference

12 December 2020

Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domain

1 reference

12 December 2020

Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins

1 reference

12 December 2020

Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein

1 reference

12 December 2020

Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells.

1 reference

12 December 2020

Interaction of HIV-1 Tat with Puralpha in nuclei of human glial cells: characterization of RNA-mediated protein-protein binding

1 reference

12 December 2020

HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses

1 reference

12 December 2020

Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells.

1 reference

12 December 2020

The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing

1 reference

12 December 2020

The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases

1 reference

12 December 2020

HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency

1 reference

12 December 2020

Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1.

1 reference

12 December 2020

Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a

1 reference

12 December 2020

Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity

1 reference

12 December 2020

Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus

1 reference

12 December 2020

Interleukin-6 production in "normal" and HTLV-1 tax-expressing brain-specific endothelial cells

1 reference

12 December 2020

Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein.

1 reference

12 December 2020

Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction

1 reference

12 December 2020

HIV-1 protein Tat reduces the glutamate-induced intracellular Ca2+ increase in cultured cortical astrocytes

1 reference

12 December 2020

Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum.

1 reference

12 December 2020

HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes.

1 reference

12 December 2020

Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture

1 reference

12 December 2020

Multifaceted activities of the HIV-1 transactivator of transcription, Tat.

1 reference

12 December 2020

Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-gamma in macrophages

1 reference

12 December 2020

Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine

1 reference

12 December 2020

The combination of methamphetamine and of the HIV protein, Tat, induces death of the human neuroblastoma cell line, SH-SY5Y.

1 reference

12 December 2020

Structural and functional characterization of human immunodeficiency virus tat protein

1 reference

12 December 2020

Keto/enol epoxy steroids as HIV-1 Tat inhibitors: structure-activity relationships and pharmacophore localization

1 reference

12 December 2020

Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes

1 reference

12 December 2020

Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.

1 reference

12 December 2020

Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat.

1 reference

12 December 2020

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

1 reference

12 December 2020

Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus

1 reference

12 December 2020

Effects of cocaine and its oxidative metabolites on mitochondrial respiration and generation of reactive oxygen species.

1 reference

12 December 2020

Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine

1 reference

12 December 2020

HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR

1 reference

12 December 2020

Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats

1 reference

12 December 2020

Molecular basis for interactions of HIV and drugs of abuse.

1 reference

12 December 2020

Neurotoxicity of HIV-1 Tat protein: involvement of D1 dopamine receptor

1 reference

12 December 2020

HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter

1 reference

12 December 2020

Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia

1 reference

12 December 2020

HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium

1 reference

12 December 2020

Tat acetylation modulates assembly of a viral-host RNA-protein transcription complex

1 reference

12 December 2020

Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures

1 reference

12 December 2020

Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum

1 reference

12 December 2020

Tetrahydropyrimidine derivatives inhibit binding of a Tat-like, arginine-containing peptide, to HIV TAR RNA in vitro

1 reference

12 December 2020

HIV-1 tat protein induces the production of interleukin-8 by human brain-derived endothelial cells

1 reference

12 December 2020

Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains

1 reference

12 December 2020

Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein

1 reference

12 December 2020

Permeability of the blood-brain barrier to HIV-1 Tat.

1 reference

12 December 2020

Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro

1 reference

12 December 2020

Molecular cloning and characterization of a novel TBP-1 interacting protein (TBPIP):enhancement of TBP-1 action on Tat by TBPIP.

1 reference

12 December 2020

TAT-PAX6 protein transduction in neural progenitor cells: a novel approach for generation of dopaminergic neurones in vitro

1 reference

12 December 2020

HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology

1 reference

12 December 2020

The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons.

1 reference

12 December 2020

Cytomegalovirus and human herpesvirus-6 trans-activate the HIV-1 long terminal repeat via multiple response regions in human fetal astrocytes.

1 reference

12 December 2020

Human immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglia cultures

1 reference

12 December 2020

Neurotoxic mechanisms of transactivating protein Tat of Maedi-Visna virus

1 reference

12 December 2020

Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic

1 reference

12 December 2020

Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling

1 reference

12 December 2020

Interaction between TGFbeta signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes

1 reference

12 December 2020

Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.

1 reference

12 December 2020

Kainate receptors in hippocampal CA3 subregion: evidence for a role in regulating neurotransmitter release

1 reference

12 December 2020

Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1

1 reference

12 December 2020

Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat

1 reference

12 December 2020

NMDA receptor activation by HIV-Tat protein is clade dependent

1 reference

12 December 2020

HIV-1 clade-specific differences in the induction of neuropathogenesis

1 reference

12 December 2020

Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes

1 reference

12 December 2020

Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion

1 reference

12 December 2020

Cellular uptake of the tat protein from human immunodeficiency virus

1 reference

12 December 2020

Updated research nosology for HIV-associated neurocognitive disorders

1 reference

12 December 2020

HIV-1 Tat protein mimicry of chemokines

1 reference

12 December 2020

HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity

1 reference

12 December 2020

Glutamate, nitric oxide and cell-cell signalling in the nervous system

1 reference

12 December 2020

HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells.

1 reference

12 December 2020

HIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial Hyperpolarization

1 reference

12 December 2020

Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences

1 reference

12 December 2020

Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat.

1 reference

12 December 2020

10.1007/S12640-009-9047-8

Identifiers

DOI

1 reference

20 August 2017

1 reference